Prosecution Insights
Last updated: April 19, 2026

Catalent Pharma Solutions LLC

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18532395 MULTIFUNCTIONAL PROTEIN MOLECULES COMPRISING DECORIN AND USE THEREOF LU, CHENG 1642 Final Rejection Dec 07, 2023
18007568 NUCLEIC ACID CONSTRUCTS FOR PROTEIN MANUFACTURE KONOPKA, CATHERINE ANNE 1635 Non-Final OA Dec 01, 2022

Managing Catalent Pharma Solutions LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month